Hybrid coronary revascularization using robotic totally endoscopic surgery: perioperative outcomes and 5-year results
- PMID: 23103003
- DOI: 10.1016/j.athoracsur.2012.05.041
Hybrid coronary revascularization using robotic totally endoscopic surgery: perioperative outcomes and 5-year results
Abstract
Background: Hybrid coronary revascularization combines minimally invasive coronary artery bypass grafting and catheter-based interventions. This treatment option represents a viable alternative to both open multivessel coronary bypass surgery through sternotomy and multivessel percutaneous coronary intervention. The surgical component of hybrid coronary intervention can be offered in a completely endoscopic fashion using robotic technology. We report on one of the largest series to date.
Methods: From 2001 to 2011, 226 patients (age, 61 years [range, 31 to 90 years]; 77.0% male; EuroSCORE, 2 [range, 0 to 13]) underwent hybrid coronary interventions on an intention-to-treat basis. Robotically assisted procedures were performed using the daVinci, daVinci S, and daVinci Si surgical telemanipulation systems (Intuitive Surgical, Inc, Sunnyvale, CA) and included 147 single, 72 double, and 7 triple endoscopic coronary artery bypass grafting procedures. Surgery was carried out first in 160 cases (70.8%), percutaneous coronary intervention was carried out first in 38 cases (16.8%), and 28 patients underwent simultaneous operations in a hybrid operating room (12.4%). Drug-eluting stents were used in 70.0% of the patients.
Results: Hospital mortality was 3 of 226 patients (1.3%), and hospital stay averaged 6 days (range, 3 to 54 days). Patients walked outside 7 days (range, 3 to 97 days) postoperatively and performed general household work 14 days (range, 7 to 180 days) postoperatively. Full activity was resumed at 42 days (range, 7 to 720 days). Five-year survival was 92.9%, and 5-year freedom from major adverse cardiac and cerebral events was 75.2%. At 5 years, 2.7% of bypass grafts and 14.2% of percutaneous coronary intervention targets needed reintervention.
Conclusions: Robotically assisted hybrid coronary intervention enables surgical treatment of multivessel coronary artery disease with minimal trauma. Perioperative results and intermediate-term outcomes meet the standards of open coronary artery bypass grafting. Recovery time is short, and reintervention rates are acceptable.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Advanced hybrid closed chest revascularization: an innovative strategy for the treatment of multivessel coronary artery disease†.Eur J Cardiothorac Surg. 2014 Dec;46(6):e94-102; discussion e102. doi: 10.1093/ejcts/ezu357. Epub 2014 Sep 25. Eur J Cardiothorac Surg. 2014. PMID: 25256825
-
Integrating coronary anastomotic connectors and robotics toward a totally endoscopic beating heart approach: review of 120 cases.Ann Thorac Surg. 2011 Sep;92(3):821-7. doi: 10.1016/j.athoracsur.2011.04.103. Ann Thorac Surg. 2011. PMID: 21871264
-
Simultaneous hybrid coronary revascularization using totally endoscopic left internal mammary artery bypass grafting and placement of rapamycin eluting stents in the same interventional session. The COMBINATION pilot study.Cardiology. 2008;110(2):92-5. doi: 10.1159/000110486. Epub 2007 Oct 31. Cardiology. 2008. PMID: 17971657
-
Robotic totally endoscopic multivessel coronary artery bypass grafting: procedure development, challenges, results.Innovations (Phila). 2012 Jan-Feb;7(1):3-8. doi: 10.1097/IMI.0b013e3182552ea8. Innovations (Phila). 2012. PMID: 22576029 Review.
-
History and current status of robotic totally endoscopic coronary artery bypass.Circ J. 2012;76(9):2058-65. doi: 10.1253/circj.cj-12-0981. Epub 2012 Aug 11. Circ J. 2012. PMID: 22893280 Review.
Cited by
-
Robotic advanced hybrid coronary revascularization: Outcomes with two internal thoracic artery grafts and stents.JTCVS Tech. 2022 Aug 27;16:76-88. doi: 10.1016/j.xjtc.2022.08.012. eCollection 2022 Dec. JTCVS Tech. 2022. PMID: 36510526 Free PMC article.
-
Hybrid coronary revascularization for the treatment of multivessel coronary artery disease.Ann Cardiothorac Surg. 2018 Jul;7(4):500-505. doi: 10.21037/acs.2018.06.09. Ann Cardiothorac Surg. 2018. PMID: 30094214 Free PMC article.
-
Robotic technology in cardiovascular medicine.Nat Rev Cardiol. 2014 May;11(5):266-75. doi: 10.1038/nrcardio.2014.23. Epub 2014 Mar 25. Nat Rev Cardiol. 2014. PMID: 24663088 Review.
-
A review of hybrid coronary revascularization.Indian J Thorac Cardiovasc Surg. 2018 Dec;34(Suppl 3):321-329. doi: 10.1007/s12055-018-0763-7. Epub 2018 Nov 19. Indian J Thorac Cardiovasc Surg. 2018. PMID: 33060955 Free PMC article. Review.
-
Timing of Complete Revascularization in Patients with STEMI and Multivessel Disease: A Systematic Review and Meta-Analysis.Rev Cardiovasc Med. 2023 Feb 10;24(2):58. doi: 10.31083/j.rcm2402058. eCollection 2023 Feb. Rev Cardiovasc Med. 2023. PMID: 39077406 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical